Jump Financial’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.02M Buy
+1,881
New +$1.06M 0.01% 1183
2026
Q1
Sell
-4,200
Closed -$2.05M 2425
2025
Q4
$2.05M Buy
4,200
+3,046
+264% +$1.42M 0.03% 670
2025
Q3
$484K Buy
1,154
+191
+20% +$64.2K 0.01% 1308
2025
Q2
$277K Buy
+963
New +$288K ﹤0.01% 1461
2025
Q1
Sell
-1,046
Closed -$369K 2047
2024
Q4
$369K Buy
+1,046
New +$384K 0.01% 1223
2024
Q2
Sell
-9,230
Closed -$2.12M 2293
2024
Q1
$2.12M Sell
9,230
-31,436
-77% -$7.09M 0.06% 421
2023
Q4
$8.94M Buy
40,666
+39,556
+3,564% +$9.12M 0.28% 40
2023
Q3
$251K Buy
+1,110
New +$256K 0.01% 1400
2023
Q2
Sell
-1,517
Closed -$340K 2176
2023
Q1
$340K Sell
1,517
-57
-4% -$14.1K 0.01% 1060
2022
Q4
$438K Buy
+1,574
New +$397K 0.02% 840
2022
Q3
Sell
-1,916
Closed -$451K 1989
2022
Q2
$451K Sell
1,916
-484
-20% -$98.4K 0.02% 901
2022
Q1
$431K Buy
2,400
+227
+10% +$43.2K 0.02% 879
2021
Q4
$470K Sell
2,173
-14,659
-87% -$2.88M 0.03% 680
2021
Q3
$3.11M Buy
16,832
+11,532
+218% +$2.27M 0.22% 56
2021
Q2
$951K Buy
5,300
+2,500
+89% +$476K 0.09% 287
2021
Q1
$468K Buy
+2,800
New +$467K 0.04% 424
2020
Q4
Sell
-2,734
Closed -$276K 1191
2020
Q3
$276K Buy
+2,734
New +$300K 0.06% 526

Other funds holding UTHR

Jump Financial's UTHR Position: Q2 2026 in Review

Jump Financial opened a new position in United Therapeutics (UTHR) in Q2 2026: 1,881 shares worth $1.02M. The stake represents 0.01% of the portfolio and ranks #1183 among its holdings. This is a return to the name: Jump Financial previously reported a position in UTHR as recently as Q4 2025.

Jump Financial first reported a position in UTHR in Q3 2020 and has held it in 17 quarters since. The position peaked at $8.94M in Q4 2023. 878 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Jump Financial held 1,881 shares of United Therapeutics worth $1.02M as of Q2 2026.
  • United Therapeutics was a new Jump Financial position in Q2 2026.
  • United Therapeutics made up 0.01% of Jump Financial's portfolio in Q2 2026, its #1183 holding.
  • Jump Financial first reported a position in United Therapeutics in Q3 2020 and has held it in 17 quarters since.
  • Jump Financial's United Therapeutics position peaked at $8.94M in Q4 2023.
  • 878 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.